labetalol has been researched along with bendroflumethiazide in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Wilcox, RG | 1 |
| Dawson, A; Johnson, BF; Munro-Faure, AD; Smith, IK | 1 |
| Caterson, RJ; Collett, P; Duggin, GG; Horvath, JS; Kelly, DH; Tiller, DJ | 1 |
| Allen, B; Robinson, IG | 1 |
| Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ | 1 |
| Gomez, G | 1 |
1 review(s) available for labetalol and bendroflumethiazide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for labetalol and bendroflumethiazide
| Article | Year |
|---|---|
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Ethanolamines; Humans; Hypertension; Labetalol; Middle Aged; Physical Exertion; Pulse; Renin | 1979 |
Labetalol and bendrofluazide: comparison of their antihypertensive effects.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Placebos | 1979 |
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin | 1984 |
Labetalol in mild and moderate hypertension. A report from the General Practitioner Research Group.
Topics: Adult; Aged; Bendroflumethiazide; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Random Allocation | 1980 |
4 other study(ies) available for labetalol and bendroflumethiazide
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Labetalol and bendrofluazide.
Topics: Bendroflumethiazide; Diuretics; Drug Therapy, Combination; Ethanolamines; Humans; Hypertension; Labetalol; Sodium Chloride Symporter Inhibitors | 1979 |
The effect of different antihypertensive therapies on plasma lipids.
Topics: Aged; Bendroflumethiazide; Cholesterol; Ethanolamines; Female; Humans; Hypertension; Labetalol; Lipoproteins, HDL; Male; Middle Aged; Propranolol; Triglycerides | 1982 |